Stay updated with breaking news from Farber cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment . ....
New research by Dana-Farber Cancer Institute investigators has encouraging news for young women who have survived breast cancer and want to have children. ....
Forbes Named These Mass. Companies Best Places to Work in U.S. wupe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wupe.com Daily Mail and Mail on Sunday newspapers.
Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer Centers (NCI-DCCs). ....
A new paper by Dana-Farber Cancer Institute scientists lays the foundation for targeted therapies to inhibit activation of nuclear factor kappa B (NF-κB), a transcription factor that plays a role in various autoimmune and inflammatory diseases and cancers. ....